No heart risks from Novartis’ Parkinson’s drug

Good news for drug manufacturing company Norvatis as U.S. health regulators
said on Monday that they found
no evidence of increased
cardiovascular risks related to
Novartis AG's treatment, Stalevo,
for Parkinson's disease.

Norvatis are the manufacturer of the drug Stalevo which is used for
treating Parkinson's disease. The story would have been different if
the FDA have discovered that their drug linked to any cardiovascular
disease.

Related Posts

• Horror! Couple shot dead by ‘neighbour who blamed them for infecting his family with Covid that killed his dad and brother’This was a terrible news from Brazil as a COUPLE in Brazil have reportedly been shot dead by a neighbour who “blamed them for infecting his family with Covid,” … Read More
• Civil rights leader, Rev. Jesse Jackson Sr. and wife hospitalized after testing positive for COVID-19 months after receiving Pfizer vaccineAccording to a statement released by the prominent political activist's organization, the Rainbow PUSH Coalition, the reverend, who is 79 years old, and Jacquel… Read More
• See the illness Obasanjo has been battling for the past 35 years Former President Olusegun Obasanjo has disclosed that he has been battling diabetes for the past 35 years.Obasanjo made the disclosure at the closing cere… Read More
• Nicole Kidman Got An Exemption To Hong Kong's QuarantineThe government said it granted the exemption to the actress "for the purpose of performing designated professional work." Some Hong Kong lawmakers criticized th… Read More
• ntia: Ex-Liverpool star, Terry McDermott become the latest football legend to be diagnosed with the sickness69-year-old, Terry McDermott, who made 329 appearances and scored 81 goals for the club between 1974 and 1982, has announced he is in the early stages of Lewy B… Read More